Skip to main content

Highlights:

  • Annual Report 2018 is available for download on the Pharming website today at www.pharming.com/investors/financial-documents
  • Printed copies will be available from mid-April upon application to info@pharming.com
  • Pharming also announces a provisional commitment to invest in a minority stake in its fill & finish partner BioConnection BV

Pharming Group N.V. announces publication of its Annual Report for the financial year ended 31 December 2018. The Company also announces that it has made a provisional commitment to invest up to €1.6 million in cash and convert €2.5 million of prepayments into equity in its fill & finish partner BioConnection BV, which manufactures the final sealed vials of Pharming’s product RUCONEST®  from the purified drug substance.

“BioConnection has been an excellent partner for Pharming for many years, and is an important part of our future plans."

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline